GILD’s push with Quad is not going to make life easier for MRK’s Vicriviroc. As an addendum to the comments in #msg-46179919, I would go so far as to say that Vicriviroc more than likely has no future.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.